Navigation Links
Clarient Announces Fourth Quarter and Year-End 2007 Financial Results
Date:3/31/2008

Quarterly Revenue and Case Volumes Increase 53% and 52% Respectively

Year-over-Year

ALISO VIEJO, Calif., March 31 /PRNewswire-FirstCall/ -- Clarient, Inc. (Nasdaq: CLRT), a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced financial results for the fourth quarter and year ended December 31, 2007. Revenue from continuing operations was $12.4 million for the fourth quarter of 2007, an increase of over 53 percent compared to $8.1 million for the comparable period in 2006.

Total patient case volume for the fourth quarter of 2007 was approximately 21,500, an increase of 52 percent compared to the comparable period in 2006. Sequential total patient test volume in comparison to the third quarter of 2007 increased 10 percent, including a 6 percent increase in breast prognostics/solid tumor testing, an 18 percent increase in leukemia/lymphoma volumes, and a 12 percent increase in PCR/molecular testing volumes.

Clarient reported $6.4 million in gross profit for the fourth quarter of 2007, an increase of 78 percent as compared to $3.6 million for the comparable period in 2006. Reported gross margin in the fourth quarter of 2007 was 52 percent as compared to 45 percent for the same period 2006. Gross margins improved as a result of increased total patient volume, better use of the Company's capacity, improved revenue mix, improved process efficiencies and improved pricing with vendors.

Commenting on the year end results, Ron Andrews, President and CEO, said, "Our business model continued to validate that we can produce sustainable growth as we completed the quarter with a 53 percent increase in revenue over the fourth qua
'/>"/>

SOURCE Clarient, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Clarient CEO Ron Andrews to Participate in OneMedPlace Emerging Healthcare Technologies Finance Forum
2. Clarient to Commercialize Novel Breast Cancer Profile
3. CombiMatrix and Clarient Collaborate to Market, Sell Novel Genomics-Based Test for Chronic Lymphotic Leukemia (CLL)
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
6. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
7. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
8. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
9. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
10. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
11. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... , May 21, 2013  On May ... FCN ), the global business advisory firm dedicated ... value (the "Company"), announced that it has combined ... were formerly included within the Corporate Finance/Restructuring segment ... segment to form a single integrated practice whose ...
(Date:5/21/2013)... of a new study led by George Washington ... that nucleation of ice in small droplets is ... behavior at the nanoscale. The formation of ice ... research question whose answer also has important implications ... The crystallization of ice from supercooled water is ...
(Date:5/21/2013)... Clinverse, Inc. , a global ... announced today it has formed a strategic alliance ... FLS eClinical commerce platform aggregates data collected through ... ™, Aggregate Spend Solutions’ recently-launched flagship product, is ... transfer of value at investigator meetings or any ...
(Date:5/21/2013)... Many have long discussed the link between ... physicians from Clinical Psychiatry.com readdressed the topic ... and suggested using hypnotherapy and other mental ... stress that cause acne. , Doctors in the article ... about, stress causes changes in the skin that have ...
Breaking Biology Technology:FTI Consulting Releases Realigned Segment Information Reflecting Newly Combined Health Solutions Practice 2Study led by GW professor provides better understanding of water's freezing behavior at nanoscale 2Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 2Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 3Adult Acne Treatment, Probiotic Action Explains How Hypnotherapy and Probiotics May Cure Various Skin Conditions 2
... Novel Proteasome Inhibitor in ... Myeloma, SOUTH SAN FRANCISCO, Calif. and NORWALK, Conn., ... Proteolix, Inc. today,announced the enrollment of the first patient ... potent and selective proteasome,inhibitor, carfilzomib (PR-171), in patients with ...
... BioVex Inc, a biotechnology,company developing clinical stage treatments ... today that it has appointed Dr. Thaddeus,Pullano, 53, ... http://www.newscom.com/cgi-bin/prnh/20070815/NYW022 ) Previously, Dr. Pullano ... Acambis from 2003 to 2007. In this role, ...
... Science Addressing Increased Demand for Food, Feed, Fuel, ... DuPont (NYSE: DD ),Chairman and CEO Charles ... Officer Thomas M. Connelly, and Group Vice President ... updated investors on DuPont,businesses serving the agriculture and ...
Cached Biology Technology:The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma 2The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma 3The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma 4BioVex Appoints Dr. Thaddeus Pullano as VP, Quality Assurance 2DuPont Leaders Brief Investors on Agriculture Businesses 2DuPont Leaders Brief Investors on Agriculture Businesses 3
(Date:5/22/2013)... Calif., May 22, 2013 Early screening for prostate ... pregnancy testing is for women, thanks to UC Irvine ... American Chemical Society . , After more than a ... way to clearly identify clinically usable markers for prostate ... detected far sooner, with greater accuracy and at dramatically ...
(Date:5/22/2013)... YORK, May 22, 2013. Plastic additives known as ... about everywhere: They turn up in flooring, plastic ... to the Centers for Disease Control and Preventionthe ... phthalates have come under increasing scrutiny. A growing ... (which can leech from packaging and mix with ...
(Date:5/21/2013)... device attached to a whale entangled in fishing gear, ... changed a whale,s diving and swimming behavior. The monitoring ... and migrate, depletes their energy as they drag gear ... slow death. , The scientists in this entanglement response ... two-year-old female North Atlantic right whale called Eg 3911. ...
Breaking Biology News(10 mins):UCI chemists devise inexpensive, accurate way to detect prostate cancer 2UCI chemists devise inexpensive, accurate way to detect prostate cancer 3Study links chemicals widely found in plastics and processed food to elevated blood pressure in children and teens 2Study reveals how fishing gear can cause slow death of whales 2Study reveals how fishing gear can cause slow death of whales 3
... went looking for fossil whales and dinosaurs in Saudi Arabia, ... primate fossil. But the skull he stumbled upon ... apes and monkeys may have looked like and when the ... at the University of Michigan and the Saudi Geological Survey ...
... Rice University scientists have found the "ultimate" solvent for ... brings the creation of a highly conductive quantum nanowire ... of bundling, making them less useful than when they,re ... Pasquali, a professor in chemical and biomolecular engineering and ...
... at the U.S. Department of Energy,s Savannah River ... and Mississippi State University to decrease mold growth ... Funded by the Department of Homeland ... (SERRI), Mississippi State University asked SRNL and Tuskegee ...
Cached Biology News:Fossil find puts a face on early primates 2Fossil find puts a face on early primates 3Fossil find puts a face on early primates 4Nanotubes pass acid test 2Nanotubes pass acid test 3SRNL works to decrease hazards from mold in water damaged homes 2